Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The development of hollow ferrogadolinium nanonetworks has not been reported for nanomedicine application until now. In this study, we developed a hollow and porous ferrogadolinium nanonetwork structure using the one-pot solvothermal method. This nanoparticle could be simultaneously used as a T 1 and T 2 dual-modal magnetic resonance imaging (MRI) contrast agent. In addition, the hollow lumen and abundant pores of the nanonetworks maximized the loading capacity and conferred the nanoplatforms for suitable anticancer drug loading capacity. Using these nanonetworks, MRI and anticancer experiments were conducted in vitro and satisfactory dual-modal MRI and cancer chemotherapy results were obtained. Therefore, the nanonetworks with dual-modal MRI and drug loading abilities effectively complement the ferrogadolinium composites' library and hold great promise in nanomedicine for simultaneous cancer diagnosis and chemotherapy.

Cite

CITATION STYLE

APA

Tang, T., Sun, X., Xu, X., Bian, Y., Ma, X., & Chen, N. (2019). Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy. RSC Advances, 9(5), 2559–2566. https://doi.org/10.1039/c8ra09102a

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free